Literature DB >> 28939934

Status quo of delirium management in German-speaking countries: comparison between intensive care units and wards.

Susanne Krotsetis1, Peter Nydahl2, Rolf Dubb3, Carsten Hermes4, Arnold Kaltwasser3, Rebecca von Haken5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28939934     DOI： 10.1007/s00134-017-4945-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  The intensive care delirium research agenda: a multinational, interprofessional perspective.

Authors:  Pratik P Pandharipande; E Wesley Ely; Rakesh C Arora; Michele C Balas; Malaz A Boustani; Gabriel Heras La Calle; Colm Cunningham; John W Devlin; Julius Elefante; Jin H Han; Alasdair M MacLullich; José R Maldonado; Alessandro Morandi; Dale M Needham; Valerie J Page; Louise Rose; Jorge I F Salluh; Tarek Sharshar; Yahya Shehabi; Yoanna Skrobik; Arjen J C Slooter; Heidi A B Smith
Journal:  Intensive Care Med       Date:  2017-06-13       Impact factor: 17.440

2.  Survey among critical care nurses and physicians about delirium management.

Authors:  Peter Nydahl; Michael Dewes; Rolf Dubb; Carsten Hermes; Arnold Kaltwasser; Susanne Krotsetis; Rebecca von Haken
Journal:  Nurs Crit Care       Date:  2017-05-18       Impact factor: 2.325

Review 3.  Occurrence and outcome of delirium in medical in-patients: a systematic literature review.

Authors:  Najma Siddiqi; Allan O House; John D Holmes
Journal:  Age Ageing       Date:  2006-04-28       Impact factor: 10.668

4.  Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study.

Authors:  Jason E Tomichek; Joanna L Stollings; Pratik P Pandharipande; Rameela Chandrasekhar; E Wesley Ely; Timothy D Girard
Journal:  Crit Care       Date:  2016-11-24       Impact factor: 9.097

Review 5.  Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) - short version.

Authors:  Ralf Baron; Andreas Binder; Rolf Biniek; Stephan Braune; Hartmut Buerkle; Peter Dall; Sueha Demirakca; Rahel Eckardt; Verena Eggers; Ingolf Eichler; Ingo Fietze; Stephan Freys; Andreas Fründ; Lars Garten; Bernhard Gohrbandt; Irene Harth; Wolfgang Hartl; Hans-Jürgen Heppner; Johannes Horter; Ralf Huth; Uwe Janssens; Christine Jungk; Kristin Maria Kaeuper; Paul Kessler; Stefan Kleinschmidt; Matthias Kochanek; Matthias Kumpf; Andreas Meiser; Anika Mueller; Maritta Orth; Christian Putensen; Bernd Roth; Michael Schaefer; Rainhild Schaefers; Peter Schellongowski; Monika Schindler; Reinhard Schmitt; Jens Scholz; Stefan Schroeder; Gerhard Schwarzmann; Claudia Spies; Robert Stingele; Peter Tonner; Uwe Trieschmann; Michael Tryba; Frank Wappler; Christian Waydhas; Bjoern Weiss; Guido Weisshaar
Journal:  Ger Med Sci       Date:  2015-11-12
  5 in total
  3 in total

Review 1.  [Pitfalls in the diagnosis of delirium].

Authors:  Peter Nydahl; Ulf Günther; Hans-Christian Hansen; Johannes Meyne; Jürgen Osterbrink; Nils G Margraf
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-08-12       Impact factor: 0.840

2.  [Disorientation and delirium assessment : A secondary analysis of a prospective, observational study].

Authors:  Ulf Guenther; Mirko Wolke; Hans-Christian Hansen; Nicole Feldmann; Anja Diers; Oliver Dewald; E Wesley Ely; Andreas Weyland
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-08-25       Impact factor: 1.552

3.  Delirium on stroke units: a prospective, multicentric quality-improvement project.

Authors:  Peter Nydahl; Friederike Baumgarte; Daniela Berg; Manuela Bergjan; Christoph Borzikowsky; Christiana Franke; Diana Green; Anisa Hannig; Hans Christian Hansen; Armin Hauss; Uta Hansen; Rahel Istel; Norma Krämer; Karita Krause; Renée Lohrmann; Mohammad Mohammadzadeh-Vazifeh; Jürgen Osterbrink; Frederick Palm; Telse Petersen; Bernd Schöller; Henning Stolze; Max Zilezinski; Johannes Meyne; Nils G Margraf
Journal:  J Neurol       Date:  2022-02-14       Impact factor: 6.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.